A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT04547166 · RECRUITING
Trial details
- NCT number
- NCT04547166
- Sponsor
- Shanghai Henlius Biotech
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2025-09-24
- Enrollment
- 568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.